secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0001193125-25-139899
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics raises ~$4.6M gross in registered direct offering of stock and prefunded warrants
--------------------------------------------------------------------------------

- Issued 405,000 shares at $6.25 each and prefunded warrants for 334,000 shares at $6.249 each.
- Net proceeds estimated at ~$4.1M after placement agent fees and expenses.
- Proceeds to support strategic alternative process and working capital; cash runway into Q2 2026.
- Placement agent H.C. Wainwright receives 6.0% cash fee on gross proceeds.
- Prefunded warrants exercisable at $0.001 per share, with 4.99% beneficial ownership limitation (holder may elect up to 9.99%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312525139899/0001193125-25-139899-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312525139899/d908664d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-139899

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer